Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87M Buy
37,890
+626
+2% +$73.3K 0.33% 62
2026
Q1
$4.48M Sell
37,264
-75
-0.2% -$8.66K 0.34% 62
2025
Q4
$3.93M Buy
37,339
+166
+0.4% +$15.6K 0.29% 68
2025
Q3
$3.12M Sell
37,173
-15,512
-29% -$1.28M 0.24% 98
2025
Q2
$4.17M Buy
52,685
+6,732
+15% +$535K 0.34% 58
2025
Q1
$4.12M Buy
45,953
+45,906
+97,672% +$4.29M 0.35% 51
2024
Q4
$4.69K Sell
47
-49,732
-100% -$5.13M 0.43% 36
2024
Q3
$5.65M Buy
49,779
+2,207
+5% +$262K 0.47% 30
2024
Q2
$5.89M Buy
47,572
+21,058
+79% +$2.71M 0.54% 27
2024
Q1
$3.5M Buy
26,514
+1,507
+6% +$186K 0.33% 60
2023
Q4
$2.73M Sell
25,007
-2,175
-8% -$226K 0.27% 82
2023
Q3
$2.8M Buy
+27,182
New +$2.93M 0.31% 71

Other funds holding MRK

NBC Securities's MRK Position: Q2 2026 in Review

NBC Securities increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $73.3K and bringing the position to 37,890 shares worth $4.87M. The position accounts for 0.33% of the portfolio, ranked #62.

NBC Securities first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.89M in Q2 2024. 874 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • NBC Securities held 37,890 shares of Merck worth $4.87M as of Q2 2026.
  • NBC Securities bought 626 Merck shares in Q2 2026, an estimated $73.3K.
  • Merck made up 0.33% of NBC Securities's portfolio in Q2 2026, its #62 holding.
  • NBC Securities first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Merck position peaked at $5.89M in Q2 2024.
  • 874 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.